CD8A and neoplasm: In most solid tumors, various reasons lead to a low burden of intracellular mutant antigens or down-regulation of MHC molecule expression in tumor cells, resulting in tumor cells being insufficient to be recognized by TCRs or unable to trigger the expansion and functional activation of CD8+ Teff after TCRs recognition [12–14].